Images
Participants
Contact
Report on the main approaches being developed by top Spanish scientists of international standing to find new therapeutic options against cancer.
The report highlights the work conducted on CPBE proteins by Raúl Méndez, ICREA researcher in IRB’s Molecular Medicine Programme, and the research by Joan Massagué, cofounder of IRB and current chair of the International Scientific Board of the centre, on metastasis, which is being addressed from his lab in the Memorial Sloan Kettering Cancer Center.
The Oncology Programme of IRB is also engaged in innovative projects in cancer metastases, mainly focused on those derived from cancer of the breast, colon and skin.
Read the report in La Vanguardia (PDF)
Related news
24 February 2013
Researchers at IRB Barcelona discover a general mechanism that accelerates tumor development
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
